April 25th 2025
An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Can MRI Surveillance Have an Impact in Detecting Recurrence of Soft Tissue Sarcomas?
February 3rd 2023While acknowledging a moderate to high risk of bias in the retrospective studies reviewed for a recent meta-analysis, researchers found the current evidence supports the use of high-intensity magnetic resonance imaging (MRI) surveillance for detection of soft tissue sarcoma recurrence.
New MRI Study Examines Impact of Disparities with Childhood Adversity Exposure on Brain Development
February 2nd 2023In a study of over 9,000 children that examined structural magnetic resonance imaging (MRI) data as well as parent and child self-reporting of adversity-related measures, researchers found that greater exposure to adversities for Black children was linked to lower gray matter volume in the amygdala and multiple subregions of the prefrontal cortex in comparison to White children.
New Meta-Analysis Says MRI is Best Supplemental Imaging for Dense Breasts
January 31st 2023In a review of 22 studies and data from over 132,000 women with dense breasts and negative mammography exams, researchers found that magnetic resonance imaging (MRI) was superior to digital breast tomosynthesis, handheld ultrasound and automated whole breast ultrasound for the detection of breast cancer.
What a New Study Reveals About MRI Use and Implantable Cardioverter Defibrillators
January 31st 2023In a prospective study of over 600 patients, researchers found that magnetic resonance imaging (MRI) had no serious adverse effects upon the detection of tachyarrhythmias with non-MRI conditional implantable cardioverter defibrillators (ICDs).
Abbreviated MRI and Early-Stage Hepatocellular Carcinoma: What a New Multicenter Study Reveals
January 25th 2023In a multicenter study involving nearly 300 patients, researchers found that abbreviated magnetic resonance imaging (MRI) had a sensitivity rate of 88.2 percent and a specificity rate of 89.1 percent for detecting early-stage hepatocellular carcinoma (HCC).
Meta-Analysis Reaffirms Benefits of O-RADS MRI for Diagnosing Indeterminate Adnexal Lesions
December 16th 2022In addition to summary sensitivity and specificity of 92 percent and 91 percent respectively for characterization of indeterminate adnexal lesions, the meta-analysis on pelvic magnetic resonance imaging (MRI) revealed higher summary malignancy rates for O-RADS MRI 4 and 5 lesions than predicted.
What BI-RADS Changes Are on the Way for Breast MRI Reporting?
December 2nd 2022In a recent lecture at the Radiological Society of North America (RSNA) conference, Wendy DeMartini, MD, discussed a variety of preliminary proposed changes to the Breast Imaging Reporting and Data System (BI-RADS) for breast magnetic resonance imaging (MRI) examinations.
Can Emerging AI-Guided Software Rein in Scan Times for Cardiac MRI?
December 1st 2022In a recent video interview, Raymond Y. Kwong, MD, discussed his clinical experience with the Vista.ai (formerly HeartVista) One Click MRI software and recent research, presented at the Radiological Society of North America (RSNA) conference, that revealed a 31 percent decrease in cardiac MRI scan times for patients with cardiomyopathy or structural heart disease.
Enhancing MRI Efficiency and Quality: Can the New SIGNA Experience Have an Impact?
November 29th 2022Recently launched at the Radiological Society of North America (RSNA) conference, the SIGNA Experience reportedly features synergistic technologies and artificial intelligence (AI) advances that help improve the efficiency and quality of magnetic resonance imaging.
What an MRI Study Reveals About Low Alcohol Use During Pregnancy and Fetal Brain Structure
November 28th 2022Researchers found that even low amounts of alcohol consumption in pregnant women can lead to early and diffuse structural changes in brain regions related to key functions including language development.
Philips Launches AI-Enabled 'Visualization Workspace' at RSNA
November 28th 2022Offering more than 70 clinical applications, the next-generation edition of the Advanced Visualization Workspace reportedly includes enhanced liver analysis and artificial intelligence (AI)-powered scoring of early brain infarction noted on computed tomography (CT) scans for patients with ischemic stroke.
Ultra-High-Resolution MRI Identifies Enlarged Perivascular Spaces in People with Migraines
November 28th 2022New magnetic resonance imaging (MRI) research suggests a significant link between deep white matter hyperintensity severity and increased quantity of enlarged perivascular spaces in the centrum semiovale among people with migraines.
Brain MRI Study Shows 'Significant Abnormalities' Up to Six Months After COVID-19
November 21st 2022COVID-19 may cause changes in the brain stem and frontal lobe that could lead to fatigue, impacts in motor signal processing, insomnia, and depression, according to emerging research recently presented at the Radiological Society of North America (RSNA) annual conference in Chicago.
What a New MRI Study Reveals About Brain Aging and Racial Disparities
November 17th 2022New magnetic resonance imaging research shows earlier brain aging in middle-age Black individuals with researchers suggesting that cumulative exposure to stress over socioeconomic and environmental adversities may be a key contributing factor.
New MRI Study Identifies Signature White Matter Connectivity Patterns in People with Autism
November 14th 2022Emerging research has revealed findings on diffusion magnetic resonance imaging (MRI) correlational tractography that may help neuroradiologists differentiate between autism spectrum disorder (ASD) and developmental coordination disorder (DCD).
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.